The optimization of second-line therapy for metastatic colorectal cancer: new targeted therapy options

Advances in the treatment of metastatic colorectal cancer (mCRC) during the past years, largely associated with the wide use of targeted agents and effective chemotherapy regimens in routine clinical practice, as well as with the introduction of the "continuum of care" concept. This concep...

Full description

Bibliographic Details
Main Authors: E V Artamonova, L V Manzyuk
Format: Article
Language:Russian
Published: IP Habib O.N. 2016-03-01
Series:Современная онкология
Subjects:
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/27046/pdf